Park, S. J., Cerella, C., Kang, J. M., Byun, J., Kum, D., Orlikova-Boyer, B., . . . Diederich, M. Tetrahydrobenzimidazole TMQ0153 targets OPA1 and restores drug sensitivity in AML via ROS-induced mitochondrial metabolic reprogramming. BMC.
Chicago Style (17th ed.) CitationPark, Su Jung, et al. Tetrahydrobenzimidazole TMQ0153 Targets OPA1 and Restores Drug Sensitivity in AML via ROS-induced Mitochondrial Metabolic Reprogramming. BMC.
MLA (9th ed.) CitationPark, Su Jung, et al. Tetrahydrobenzimidazole TMQ0153 Targets OPA1 and Restores Drug Sensitivity in AML via ROS-induced Mitochondrial Metabolic Reprogramming. BMC.
Warning: These citations may not always be 100% accurate.